DFTX
Definium Therapeutics, Inc.
NASDAQ: DFTX · HEALTHCARE · BIOTECHNOLOGY
$21.40
-2.95% today
Updated 2026-05-11
Market cap
$2.40B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.50
Dividend yield
—
52W range
$6 – $26
Volume
1.9M
Definium Therapeutics, Inc. (DFTX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |